PMI's Dividend Yield Expected to Range from 2.1% to 5%

Jan.05.2023

PMI's 2022 dividend yield is between 2.1% to 5%. It has a market value of 157 billion dollars and owns the IQOS brand.

Phimo International's (PMI) annual dividend yield for 2022 ranges from 2.1% to 5%.

Philip Morris International (PMI) has a market value of $157 billion, which is almost equivalent to the combined total market value of its two competitors. In addition to its leading cigarette brand, Marlboro, the company also owns the top-notch heat-not-burn brand, IQOS.

Since its launch in 2014, IQOS has amassed a customer base of 19.5 million. The growth in sales of IQOS has offset the decline in sales of cigarettes, which is why PMI's overall sales grew by 3.4% in the first nine months of 2022.

Screenshot of Phimo International's revenue-related data. Source: New York Stock Exchange.

Analysts at the New York Stock Exchange predict that the company's earnings will grow at a rate of 2.8% per year over the next five years. The dividend payout ratio for PMI is expected to reach around 92% by 2022.

At first glance, this seems to be in a favorable position. However, due to the minimal capital required for tobacco companies to operate, this allocation rate should be sustainable in the short term. As PMI's dividend growth rate is lower than its earnings in the coming years, dividends are expected to be very safe.

The most significant factor is that investors can purchase the shares of this tobacco giant at a reasonable valuation and receive a 5% dividend yield. The stock's forward P/E ratio of 18.7 is higher than the tobacco industry's average forward P/E ratio of 13.4.

Special Note: This article does not provide any investment references or suggestions.

#PMI

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Selangor preparing regulatory policy that may gradually prohibit vape use

Selangor is drafting a policy paper outlining its regulatory direction for electronic cigarette products, including the possibility of gradually prohibiting vape use. The move aligns with the Tobacco Product Control Act for Public Health 2023 (Act 852) and aims to strengthen enforcement and youth health education.

Nov.21 by 2FIRSTS.ai

Alan Zhao: What Altria’s on! PLUS Authorization Really Signals About FDA PMTA Enforcement

In this in-depth commentary for 2Firsts, Alan Zhao examines what Altria’s on! PLUS authorization really signals about FDA PMTA enforcement. Beyond the headline approval, FDA’s language, process design and product choices offer rare insight into how nicotine pouch regulation is taking shape—and what it means for industry compliance, in one of the earliest expert reads of the decision.

Regulations

Dec.20

Echo Guo: The Accumulating Risks Behind the Surge in Chinese Vape Exports to the U.S.

Chinese vape exports to the U.S. jumped from about 2.2 million kg in June to 14.8 million kg in October 2025, despite tougher enforcement, the Washington Examiner reported. 2Firsts finds the surge reflects delayed bulk shipments, not demand recovery. With U.S. inventory exceeding 160 million devices and distributors paying ~10% upfront, cash-flow stress has shifted to Chinese manufacturers, and discounted stock is spilling into other markets.

Dec.14 by Echo Duo

Belgian Drug Commissioner Warns of Hidden Opioids in Illegal Vapes

Belgium’s drug commissioner Ine Van Wymersch has warned that more than 80% of illegal refillable vape capsules seized in Belgium contain synthetic opioids, posing serious risks of early addiction among children. She told Euronews that these substances, which have no distinctive smell or color, could lead to opioid dependence from a young age.